期刊
HIPPOCAMPUS
卷 24, 期 4, 页码 363-368出版社
WILEY-BLACKWELL
DOI: 10.1002/hipo.22245
关键词
epigenetics; DNA methylation; hippocampus; brain and neurodegeneration
资金
- Cellex Foundation
- Botin Foundation
- Fundacio Agrupacio Mutua
- Health and Science Departments of the Catalan Government (Generalitat de Catalunya)
- ICREA Funding Source: Custom
Genetic screening in Alzheimer's disease (AD) has identified only a handful of genes that are mutated in the disorder. Thus, for a very large proportion of patients, the biology of their disease is poorly understood. Epigenetic alterations may provide an explanation in these cases. Using DNA methylation profiles of human hippocampus from controls and patients, we have identified the presence of promoter hypermethylation of the dual-specificity phosphatase 22 (DUSP22) gene in AD. DUSP22 is a likely candidate gene for involvement in the pathogenesis of the disorder since, as we demonstrate here, it inhibits PKA activity and thereby determines TAU phosphorylation status and CREB signaling. (c) 2014 The Authors. Hippocampus Published by Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据